Fundai

Iran Capsule Gelatin Production Company (DKAPSUL) income statement

Operating revenue through to net profit and earnings per share

Ticker
DKAPSUL
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue12,702,4027,595,8064,965,2823,683,7332,882,9621,587,911
Cost of operating revenue-5,534,442-3,038,084-1,928,356-1,357,465-1,026,886-800,520
Gross profit (loss)7,167,9604,557,7223,036,9262,326,2681,856,076787,391
Selling, general and administrative expenses-797,322-353,708-277,956-149,770-112,217-73,719
Other expenses-20,164-6,7860-15,520-2,806-2,188
Operating profit (loss)6,350,4744,197,2282,759,4742,160,9781,741,053711,920
Finance costs-317,128-120,169-105,878-48,221-31,652-27,939
Other non-operating income and expenses106,37238,87138,53613,25937,57837,309
Profit (loss) from continuing operations before tax6,139,7184,115,9302,692,1322,126,0161,746,979721,290
Current year tax-1,374,323-931,825-604,908-318,491-222,431-160,142
Net profit (loss) from continuing operations4,765,3953,184,1052,087,2241,807,5251,524,548561,148
Net profit (loss)4,765,3953,184,1052,087,2241,807,5251,524,548561,148
Basic earnings (loss) per share15,887 rials10,615 rials6,972 rials6,033 rials5,090 rials2,806 rials
Net earnings (loss) per share, rials15,885 rials10,614 rials6,958 rials6,026 rials5,082 rials2,806 rials
Capital300,000300,000300,000300,000300,000200,000

Reporting periods

40 periods are on file for this report, from the period ending 1396/12/29 to the period ending 1405/06/31.